PL1993365T3 - Preparaty z biodostępnych kurkuminoidów do leczenia choroby alzheimera oraz innych zaburzeń powiązanych z wiekiem - Google Patents

Preparaty z biodostępnych kurkuminoidów do leczenia choroby alzheimera oraz innych zaburzeń powiązanych z wiekiem

Info

Publication number
PL1993365T3
PL1993365T3 PL07752521T PL07752521T PL1993365T3 PL 1993365 T3 PL1993365 T3 PL 1993365T3 PL 07752521 T PL07752521 T PL 07752521T PL 07752521 T PL07752521 T PL 07752521T PL 1993365 T3 PL1993365 T3 PL 1993365T3
Authority
PL
Poland
Prior art keywords
bioavailable
age
disease
related disorders
treating alzheimer
Prior art date
Application number
PL07752521T
Other languages
English (en)
Inventor
Sally A Frautschy
Greg M Cole
Original Assignee
Univ California
The U S Government Represented By The Dept Of Veterans Affairs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California, The U S Government Represented By The Dept Of Veterans Affairs filed Critical Univ California
Publication of PL1993365T3 publication Critical patent/PL1993365T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL07752521T 2006-03-06 2007-03-06 Preparaty z biodostępnych kurkuminoidów do leczenia choroby alzheimera oraz innych zaburzeń powiązanych z wiekiem PL1993365T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77981706P 2006-03-06 2006-03-06
PCT/US2007/005829 WO2007103435A2 (en) 2006-03-06 2007-03-06 Bioavailable curcuminoid formulations for treating alzheimer's disease and other age-related disorders
EP07752521.0A EP1993365B1 (en) 2006-03-06 2007-03-06 Bioavailable curcuminoid formulations for treating alzheimer's disease and other age-related disorders

Publications (1)

Publication Number Publication Date
PL1993365T3 true PL1993365T3 (pl) 2013-10-31

Family

ID=38475534

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07752521T PL1993365T3 (pl) 2006-03-06 2007-03-06 Preparaty z biodostępnych kurkuminoidów do leczenia choroby alzheimera oraz innych zaburzeń powiązanych z wiekiem

Country Status (5)

Country Link
US (1) US9192644B2 (pl)
EP (1) EP1993365B1 (pl)
ES (1) ES2427216T3 (pl)
PL (1) PL1993365T3 (pl)
WO (1) WO2007103435A2 (pl)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080193573A1 (en) * 2006-03-17 2008-08-14 Gow Robert T Extracts and methods comprising curcuma species
US8580954B2 (en) 2006-03-28 2013-11-12 Hospira, Inc. Formulations of low dose diclofenac and beta-cyclodextrin
AU2009269530A1 (en) * 2008-07-07 2010-01-14 Laila Pharmaceuticals Pvt. Ltd. Orally active curcuminoid compounds
US9700525B2 (en) 2008-08-20 2017-07-11 Board Of Supervisors Of Louisiana State University And Agricultural & Mechanical College Continuous local slow-release of therapeutics for head and neck problems and upper aerodigestive disorders
CN102176920B (zh) * 2008-11-17 2013-09-18 莱拉制药用品私营有限责任公司 姜黄素及其用于治疗眼科疾病的方法
WO2010068935A2 (en) * 2008-12-11 2010-06-17 Human Biomolecular Research Institute Small molecule immunomodulators for alzheimer's disease
RU2532384C2 (ru) * 2009-03-20 2014-11-10 Байокстракт С.А. Фармацевтическая композиция, проявляющая противовоспалительные свойства
US9393198B2 (en) 2010-03-22 2016-07-19 Signpath Pharma Inc. Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders
WO2012023142A2 (en) * 2010-08-18 2012-02-23 Clearfarma Industries Ltd. Functional food compositions and methods
EP2616053B1 (en) * 2010-09-15 2016-11-02 Cadila Pharmaceuticals Ltd. Pharmaceutical compositions of curcumin
EP2627195B1 (en) * 2010-10-14 2014-08-20 Abbott GmbH & Co. KG Curcuminoid solid dispersion formulation
JP5868414B2 (ja) * 2010-11-08 2016-02-24 カディラ ファーマシューティカルズ リミテッド タキソイドの医薬組成物
US8785380B2 (en) 2011-02-01 2014-07-22 M/S Akay Flavours & Aromatics Pvt Ltd. Formulation containing curcuminoids exhibiting enhanced bioavailability
EP2709607B1 (en) 2011-05-16 2017-01-11 OmniActive Health Technologies Limited A water soluble composition comprising curcumin having enhanced bioavailability and process thereof
US10449193B2 (en) 2011-06-03 2019-10-22 Signpath Pharma Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies
US12004868B2 (en) 2011-06-03 2024-06-11 Signpath Pharma Inc. Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel
US10238602B2 (en) 2011-06-03 2019-03-26 Signpath Pharma, Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies
US10117881B2 (en) 2011-06-03 2018-11-06 Signpath Pharma, Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC against drugs that cause channelopathies
US10349884B2 (en) 2011-06-03 2019-07-16 Sighpath Pharma Inc. Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel
CA2836904C (en) 2011-06-03 2019-09-24 Signpath Pharma Inc. Liposomal mitigation of drug-induced long qt syndrome and potassium delayed-rectifier current
CN102274163B (zh) * 2011-08-12 2013-01-02 山东大学 一种姜黄素纳米胶束制剂及其制备方法
WO2013086330A1 (en) * 2011-12-08 2013-06-13 Abbott Laboratories Nutritional compositions comprising curcumin and docosahexaenoic acid for improving cognition
EP2804587B1 (en) 2012-01-19 2019-05-08 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Formulation and method for increasing oral bioavailability of drugs
WO2013176555A1 (en) * 2012-05-22 2013-11-28 Cave Harold Gordon Improved complexes and compositions containing curcumin
AU2013274105A1 (en) 2012-06-14 2014-12-18 Signpath Pharma, Inc. Method and system for measuring the pharmacokinetics of liposomal curcumin and its metabolite tetrahydrocurcumin
CA2882978A1 (en) * 2012-08-31 2014-03-06 University Of North Texas Health Science Center Curcumin-er, a liposomal-plga sustained release nanocurcumin for minimizing qt prolongation for cancer therapy
RU2494733C1 (ru) * 2012-10-16 2013-10-10 Всеволод Иванович Киселев Фармацевтическая композиция на основе фитонутриентов с повышенной биодоступностью, обладающая противоопухолевой активностью, и способ ее получения (варианты)
CN104797144B (zh) 2012-11-26 2017-10-20 捷通国际有限公司 抗氧化剂膳食补充剂
CN102949375B (zh) * 2012-11-28 2015-04-08 厦门大学附属第一医院 一种盐酸小檗碱固体脂质纳米制剂及其制备方法
US20160000714A1 (en) 2013-03-06 2016-01-07 Capsugel Belgium Nv Curcumin solid lipid particles and methods for their preparation and use
CA2931255A1 (en) * 2013-11-27 2015-06-04 Research Foundation Of The City University Of New York Activity enhancing curcumin compositions and methods of use
CA2933204C (en) 2013-12-18 2020-04-28 Signpath Pharma, Inc. Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel
CN103784421B (zh) * 2014-02-27 2016-04-27 哈尔滨医科大学 载姜黄素和胡椒碱的固体脂质纳米粒及其制备方法
WO2015187883A1 (en) 2014-06-03 2015-12-10 Signpath Pharma, Inc. Protective effect of dmpc, dmpg, dmpc/dmpg, egpg, lysopg and lysopc against drugs that cause channelopathies
WO2015186144A2 (en) * 2014-06-07 2015-12-10 Laila Pharmaceuticals Pvt. Ltd. Method of inhibition of beta-secretase by using bis-o-demethylcurcumin for the prevention, management and treatment of neurodegenerative diseases
EP3218006A4 (en) * 2014-11-11 2018-08-15 Verdure Sciences Stable solid lipid particle composition for improved bioavailability of lipophilic compounds for age-related diseases
US11324699B2 (en) 2014-12-04 2022-05-10 Capsugel Belgium Nv Lipid multiparticulate formulations
US10639285B2 (en) 2014-12-15 2020-05-05 Aurea Biolabs Private Limited Process for preparation of bioavailable white curcumin—a unique blend of hydrogenated curcuminoids
DK3381451T3 (da) * 2015-08-28 2025-10-06 Caliway Biopharmaceuticals Co Ltd Farmaceutisk sammensætning brugt til at reducere lokaliseret fedt samt brug af den farmaceutiske sammensætning
US11318110B2 (en) 2015-08-28 2022-05-03 Caliway Biopharmaceuticals Co., Ltd. Pharmaceutical composition for reducing local fat and uses thereof
US20170071901A1 (en) * 2015-09-15 2017-03-16 Guodong Zhang Methods and formulations for increasing chemical stability and biological activity of phenolic compounds
KR101867184B1 (ko) * 2015-11-30 2018-06-14 (의료)길의료재단 진세노사이드를 포함하는 커큐민 함유 지질나노입자 복합체 및 그의 제조방법
KR102603673B1 (ko) 2016-04-27 2023-11-17 사인패스 파마 인코포레이티드 약물 유발된 방실 차단의 방지
US10076552B2 (en) 2016-08-09 2018-09-18 DATT MEDIPRODUCTS LIMITED and DATT LIFE SCIENCE PVT. LTD. Multifunctional formulation comprised of natural ingredients and method of preparation/manufacturing thereof
US10716824B2 (en) 2016-08-26 2020-07-21 Caliway Biopharmaceuticals Co., Ltd. Subcutaneous injection formulation for reducing body weight and uses thereof
EP3290026A1 (en) 2016-09-06 2018-03-07 Athenion AG Method for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents
WO2018083677A1 (en) * 2016-11-07 2018-05-11 Akay Flavours & Aromatics Pvt. Ltd. Green approach in enhancing the bioavailability of oils, fats and other lipophilic bioactives and compositions thereof
EP3536332A1 (en) 2018-03-07 2019-09-11 Athenion AG Krill oil for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents
JP7671693B2 (ja) 2018-10-23 2025-05-02 スタビコン ライフ サイエンシズ プライベート リミテッド 非クルクミノイドの水溶性粒子とクルクミノイドの水溶性粒子から構成される製剤
CN109549924B (zh) * 2018-11-21 2021-05-11 四川大学华西医院 Sklb023混合胶束及其制备方法和用途
IN201811044487A (pl) * 2018-11-26 2020-08-14 Registrar, Panjab University Chandigarh
HUE066505T2 (hu) 2019-02-11 2024-08-28 Joseph Halstead Terápiásan adagolható magas dózisú nemvizes kurkuminoid oldatok
WO2020214600A1 (en) * 2019-04-14 2020-10-22 The Regents Of The University Of California A sensitive lc-ms assay to measure curcuminoids in complex biological samples
AU2020398079B2 (en) * 2019-12-03 2024-09-19 Omniactive Health Technologies Limited Curcumin compositions for osteoarthritis and joint wellness
CN111388676A (zh) * 2020-02-11 2020-07-10 湖南中茂生物科技有限公司 一种提高姜黄素水溶性的组合物及其在制备治疗老年痴呆的复方中的应用
US12390504B2 (en) 2020-03-26 2025-08-19 Verdure Sciences, Inc. Polyphenol blend of curcumin extract and pomegranate extract and methods of improving immune response
CN111568882A (zh) * 2020-06-09 2020-08-25 复旦大学附属中山医院青浦分院 一种复方姜黄素纳米粒和制备方法及其应用
EP4171530A4 (en) * 2020-06-26 2023-11-08 Pharmako Biotechnologies PTY Limited LIQUID DISPERSIBLE CURCUMINOID COMPOSITIONS AND METHODS FOR IMPROVING COGNITIVE FUNCTION
CN112315953B (zh) * 2020-11-06 2023-03-07 中国海洋大学 一种姜黄素酯在改善急性肾损伤制品中的应用
US20230390222A1 (en) * 2021-02-01 2023-12-07 The Board Of Trustees Of The Leland Stanford Junior University Amyloid-Binding Peptoids with Broad-Spectrum Antiviral, Antibacterial, and Antifungal Activity
US20230190937A1 (en) * 2021-11-05 2023-06-22 Cornell University Iron complexes of esterified derivatives of natural products, and methods of use
EP4186497A1 (en) 2021-11-26 2023-05-31 Dorian Bevec Alpha lipoic acid, epigallocatechin 3-gallate, and curcumin as a medicament for the treatment of arthritis or sars-cov-2 infection

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4263333A (en) * 1979-09-12 1981-04-21 General Foods Corporation Curcumin-metal color complexes
KR920004818B1 (ko) * 1989-11-28 1992-06-18 태평양화학 주식회사 세포 보호제 조성물
US6979441B2 (en) * 1998-09-16 2005-12-27 Wilson T Crandall Method for topical treatment of carpal tunnel syndrome
US20040266883A1 (en) * 1999-10-27 2004-12-30 Yale University Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
JP4179494B2 (ja) 2001-10-23 2008-11-12 株式会社カネカ ペルオキシソーム増殖剤応答性受容体リガンド剤
EP1501526A1 (en) * 2002-04-16 2005-02-02 Isis Innovation Limited Curcumin for the prevention and/or treatment of tissue damage
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
AU2003270283A1 (en) * 2002-10-01 2004-04-23 Dr. Andre Rieks - Labor Fur Enzymtechnologie Gmbh Novel curcumin/tetrahydrocurcumin derivatives for using in cosmetics, pharmaceuticals and for nutrition
ITMI20022323A1 (it) * 2002-10-31 2004-05-01 Maria Rosa Gasco Composizioni farmaceutiche atte al trattamento di malattie oftalmiche.
US7083813B2 (en) * 2002-11-06 2006-08-01 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
WO2004080396A2 (en) * 2003-03-07 2004-09-23 The University Of Texas Md Anderson Cancer Center Liposomal curcumin for treatment of cancer
US20080103213A1 (en) * 2004-03-05 2008-05-01 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of neurofibromatosis
US20060045928A1 (en) * 2004-08-31 2006-03-02 Seiri Oshiro Composition containing herbal medicine component for promoting absorption and production method thereof
US20060228403A1 (en) * 2005-04-12 2006-10-12 Zimmerman Karl A Nutritional supplements for cardiovascular health
EP1837030A1 (en) 2006-03-09 2007-09-26 INDENA S.p.A. Phospholipid complexes of curcumin having improved bioavailability

Also Published As

Publication number Publication date
WO2007103435A2 (en) 2007-09-13
EP1993365A2 (en) 2008-11-26
WO2007103435A3 (en) 2007-10-25
EP1993365B1 (en) 2013-05-08
US9192644B2 (en) 2015-11-24
US20090324703A1 (en) 2009-12-31
EP1993365A4 (en) 2010-04-07
ES2427216T3 (es) 2013-10-29

Similar Documents

Publication Publication Date Title
PL1993365T3 (pl) Preparaty z biodostępnych kurkuminoidów do leczenia choroby alzheimera oraz innych zaburzeń powiązanych z wiekiem
EP2091566A4 (en) COMBINATION THERAPIES AGAINST ALZHEIMER DISEASE AND SIMILAR ILLNESSES
IL264736B (en) Pharmaceutical preparations containing zonisamide for use in the treatment of diseases related to Alzheimer's disease
EP2151435A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
IL205153A0 (en) Compositions for treating parkinson's disease
EP2382176A4 (en) USE OF CURCUMIN ANALOGUES CONTAINING NITROGEN FOR THE TREATMENT OF ALZHEIMER'S DISEASE
IL194789A0 (en) Terphenyl derivatives for treatment of alzheimer's disease
GB2443287B (en) Methods, compositions and formulations for the treatment of thyroid eye disease
EP1940373B8 (en) 1-fluoro-1-deoxy-scyllo-inositol for the treatment of alzheimer's disease
IL177015A0 (en) Improved modalities for the treatment of degenerative diseases of the retina
PL2197883T3 (pl) Pochodna katecholaminy użyteczna do leczenia choroby Parkinsona
IL208926A0 (en) Use of epothelone d in treating tau-associated diseases including alzheimer's disease
EP1809601A4 (en) COMPOUNDS FOR ALZHEIMER'S DISEASE
EP2306824A4 (en) IONTOPHORETIC DELIVERY OF CURCUMINE AND CURCUMINANALOGUE FOR THE TREATMENT OF MORBUS ALZHEIMER
IL185300A0 (en) New pharmaceutical compositions useful in the treatment of parkinson's disease
IL186022A0 (en) Dermatological compositions and salts for the treatment of dermatological diseases
EP2010215A4 (en) METHOD AND COMPOSITIONS FOR TREATING MORBUS CROHN
EP2214488A4 (en) COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE AND RELATED DISORDERS
IL184849A0 (en) Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation
EP2059238A4 (en) THERAPEUTIC COMPOUNDS FOR DISEASES AND DISORDERS
HU0500145D0 (en) Composition for the treatment of oral diseases
EP2099476A4 (en) METHODS OF TREATING ALZHEIMER'S DISEASE
EP1863510A4 (en) METHOD FOR TREATING PARKINSON DISEASE
TWI341204B (en) Composition and method for prevention and treatment of alzheimer's disease
ZA200708279B (en) Dermatological compositions and salts for the treatment of dermatological diseases